Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cannon, Rex
Lubar, Joel
and
Baldwin, Debora
2008.
Self-perception and Experiential Schemata in the Addicted Brain.
Applied Psychophysiology and Biofeedback,
Vol. 33,
Issue. 4,
p.
223.
Toplak, Maggie E.
Sorge, Geoff B.
Benoit, André
West, Richard F.
and
Stanovich, Keith E.
2010.
Decision-making and cognitive abilities: A review of associations between Iowa Gambling Task performance, executive functions, and intelligence.
Clinical Psychology Review,
Vol. 30,
Issue. 5,
p.
562.
Scholes, K. E.
and
Martin-Iverson, M. T.
2010.
Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
Psychological Medicine,
Vol. 40,
Issue. 10,
p.
1635.
Rabin, Rachel A.
Zakzanis, Konstantine K.
and
George, Tony P.
2011.
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis.
Schizophrenia Research,
Vol. 128,
Issue. 1-3,
p.
111.
Adida, M.
Maurel, M.
Kaladjian, A.
Fakra, E.
Lazerges, P.
Da Fonseca, D.
Belzeaux, R.
Cermolacce, M.
and
Azorin, J.-M.
2011.
Prise de décision et schizophrénie.
L'Encéphale,
Vol. 37,
Issue. ,
p.
S110.
Rubio, José Luis
Ruiz-Veguilla, Miguel
Hernández, Laureno
Barrigón, María Luisa
Salcedo, María Dolores
Moreno, Josefa María
Gómez, Emilio
Moritz, Steffen
and
Ferrín, Maite
2011.
Jumping to conclusions in psychosis: A faulty appraisal.
Schizophrenia Research,
Vol. 133,
Issue. 1-3,
p.
199.
van Toor, Désie
Roozen, Hendrik G.
Evans, Brittany E.
Rombout, Linda
Van de Wetering, Ben J. M.
and
Vingerhoets, Ad J. J. M.
2011.
The effects of psychiatric distress, inhibition, and impulsivity on decision making in patients with substance use disorders: A matched control study.
Journal of Clinical and Experimental Neuropsychology,
Vol. 33,
Issue. 2,
p.
161.
Meijer, J. H.
Dekker, N.
Koeter, M. W.
Quee, P. J.
van Beveren, N. J. M.
and
Meijer, C. J.
2012.
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Psychological Medicine,
Vol. 42,
Issue. 4,
p.
705.
Krysta, Krzysztof
Krupka-Matuszczyk, Irena
Janas-Kozik, Małgorzata
Stachowicz, Małgorzata
Szymszal, Jan
and
Rybakowski, Janusz K.
2012.
Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.
Medical Science Monitor,
Vol. 18,
Issue. 9,
p.
CR581.
Yucel, M.
Bora, E.
Lubman, D. I.
Solowij, N.
Brewer, W. J.
Cotton, S. M.
Conus, P.
Takagi, M. J.
Fornito, A.
Wood, S. J.
McGorry, P. D.
and
Pantelis, C.
2012.
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample.
Schizophrenia Bulletin,
Vol. 38,
Issue. 2,
p.
316.
Potvin, Stéphane
Stavro, Katherine
and
Pelletier, Julie
2012.
Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors.
Journal of Dual Diagnosis,
Vol. 8,
Issue. 1,
p.
35.
Rabin, Rachel A.
Zakzanis, Konstantine K.
Daskalakis, Zafiris J.
and
George, Tony P.
2013.
Effects of cannabis use status on cognitive function, in males with schizophrenia.
Psychiatry Research,
Vol. 206,
Issue. 2-3,
p.
158.
Benaiges, Irina
Serra‐Grabulosa, Josep Maria
Prat, Gemma
and
Adan, Ana
2013.
Executive functioning in individuals with schizophrenia and/or cocaine dependence.
Human Psychopharmacology: Clinical and Experimental,
Vol. 28,
Issue. 1,
p.
29.
Fond, Guillaume
Bayard, Sophie
Capdevielle, Delphine
Del-Monte, Jonathan
Mimoun, Nawale
Macgregor, Alexandra
Boulenger, Jean-Philippe
Gely-Nargeot, Marie-Christine
and
Raffard, Stéphane
2013.
A further evaluation of decision-making under risk and under ambiguity in schizophrenia.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 263,
Issue. 3,
p.
249.
Rominger, Axel
Cumming, Paul
Xiong, Guoming
Koller, Gabriele
Förster, Stefan
Zwergal, Andreas
Karamatskos, Evangelos
Bartenstein, Peter
La Fougère, Christian
and
Pogarell, Oliver
2013.
Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study.
European Neuropsychopharmacology,
Vol. 23,
Issue. 11,
p.
1606.
Bahorik, Amber L.
Newhill, Christina E.
and
Eack, Shaun M.
2014.
Neurocognitive Functioning of Individuals With Schizophrenia: Using and Not Using Drugs.
Schizophrenia Bulletin,
Vol. 40,
Issue. 4,
p.
856.
Løberg, Else-Marie
Helle, Siri
Nygård, Merethe
Berle, Jan Øystein
Kroken, Rune A.
and
Johnsen, Erik
2014.
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.
Frontiers in Psychiatry,
Vol. 5,
Issue. ,
Bahorik, Amber L.
Cornelius, Jack R.
Bangalore, Srihari S.
Newhill, Christina E.
Keshavan, Matcheri S.
and
Eack, Shaun M.
2014.
Brief report: The impact of alcohol and cannabis misuse on cognition among individuals with schizophrenia.
Schizophrenia Research: Cognition,
Vol. 1,
Issue. 3,
p.
160.
Colizzi, Marco
Fazio, Leonardo
Ferranti, Laura
Porcelli, Annamaria
Masellis, Rita
Marvulli, Daniela
Bonvino, Aurora
Ursini, Gianluca
Blasi, Giuseppe
and
Bertolino, Alessandro
2015.
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior.
Neuropsychopharmacology,
Vol. 40,
Issue. 3,
p.
640.
Colizzi, Marco
Iyegbe, Conrad
Powell, John
Ursini, Gianluca
Porcelli, Annamaria
Bonvino, Aurora
Taurisano, Paolo
Romano, Raffaella
Masellis, Rita
Blasi, Giuseppe
Morgan, Craig
Aitchison, Katherine
Mondelli, Valeria
Luzi, Sonija
Kolliakou, Anna
David, Anthony
Murray, Robin M.
Bertolino, Alessandro
and
Forti, Marta Di
2015.
Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.
Schizophrenia Bulletin,
Vol. 41,
Issue. 5,
p.
1171.